Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y M Mu

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Zhonghua Nei Ke Za Zhi|January 4, 2022
[Mesenchymal stem cells therapy in type 2 diabetes: problems and challenges]Y Cheng, Y M Mu
Zhonghua Nei Ke Za Zhi|December 2, 2024
[Progress of type 2 diabetes in the past decade]Y P Wang, Y M Mu
Zhonghua Nei Ke Za Zhi|March 30, 2025
[Diagnostic evaluation on bilateral adrenal lesions]P An, K Chen, Y M Mu
Zhonghua Nei Ke Za Zhi|January 8, 2026
[Efficacy and safety of osilodrostat for the treatment of Cushing's syndrome]Y Wang, Y M Mu, Y Cheng
Zhonghua Nei Ke Za Zhi|December 3, 2023
[Current status and management of obesity in China]Y P Wang, L Zang, Y M Mu
Zhonghua Nei Ke Za Zhi|October 31, 2024
[Standardized diagnosis and treatment of immune checkpoint inhibitor-induced thyroid dysfunction]B Li, W J Gu, Y M Mu
Zhonghua Nei Ke Za Zhi|December 2, 2024
[Glucokinase activators: the first step in regulating intracellular glucose metabolism]Y Hu, Y J Li, Y M Mu
Zhonghua Nei Ke Za Zhi|August 31, 2023
[Stem cell therapy in diabetes: a promising future]Y P Wang, L Zang, Y M Mu
Zhonghua Nei Ke Za Zhi|August 5, 2025
[The role of continuous glucose monitoring in diabetes screening and glycemic optimization]Y P Wang, J Wang, Y M Mu
Zhonghua Nei Ke Za Zhi|December 3, 2023
[Challenges and opportunities for assessing obesity and the complications in China: reflections on large-sample epidemiological investigation]Y J Li, W J Gu, Y M Mu
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Zhonghua Nei Ke Za Zhi|January 4, 2022
[Mesenchymal stem cells therapy in type 2 diabetes: problems and challenges]Y Cheng, Y M Mu
Zhonghua Nei Ke Za Zhi|December 2, 2024
[Progress of type 2 diabetes in the past decade]Y P Wang, Y M Mu
Zhonghua Nei Ke Za Zhi|March 30, 2025
[Diagnostic evaluation on bilateral adrenal lesions]P An, K Chen, Y M Mu
Zhonghua Nei Ke Za Zhi|January 8, 2026
[Efficacy and safety of osilodrostat for the treatment of Cushing's syndrome]Y Wang, Y M Mu, Y Cheng
Zhonghua Nei Ke Za Zhi|December 3, 2023
[Current status and management of obesity in China]Y P Wang, L Zang, Y M Mu
Zhonghua Nei Ke Za Zhi|October 31, 2024
[Standardized diagnosis and treatment of immune checkpoint inhibitor-induced thyroid dysfunction]B Li, W J Gu, Y M Mu
Zhonghua Nei Ke Za Zhi|December 2, 2024
[Glucokinase activators: the first step in regulating intracellular glucose metabolism]Y Hu, Y J Li, Y M Mu
Zhonghua Nei Ke Za Zhi|August 31, 2023
[Stem cell therapy in diabetes: a promising future]Y P Wang, L Zang, Y M Mu
Zhonghua Nei Ke Za Zhi|August 5, 2025
[The role of continuous glucose monitoring in diabetes screening and glycemic optimization]Y P Wang, J Wang, Y M Mu
Zhonghua Nei Ke Za Zhi|December 3, 2023
[Challenges and opportunities for assessing obesity and the complications in China: reflections on large-sample epidemiological investigation]Y J Li, W J Gu, Y M Mu
Pageof 8